MU Department of Medicine 2011-2013 Annual Report Feb. 2014 | Page 88
88
Annual Report
University of Missouri- Columbia
nephrology + hypertension cont.
Whaley-Connell A, Habibi J, Panfili Z, Hayden MR, Schneider
R, Bagree S, Nistala R, Parrish A, Sowers JR. Angiotensin II
activation of mTOR/S6K contributes to loss of N-cadherin and
tubulointerstitial fibrosis. Am J Nephrol 2011;29;34(2):115-125.
Whaley-Connell A, Nistala R, Chaudhary K. The importance of early
identification of Chronic Kidney Disease. Mo Med 2011:108(1):1-5.
Whaley-Connell A, Pulakat L, DeMarco VG, Hayden MR, Habibi
J, Henrikson E, Sowers JR. Over-nutrition and the Cardiorenal
Syndrome (CRS): Use of a rodent model to examine mechanism.
Cardiorenal Med 2011;1:23-30.
Whaley-Connell A, Purkayastha D, Yadao A, Sowers JR. Central
Pressure and Biomarker determination with renin inhibition in
combination with hydrochlorothiazide and ramipril in the ATTAIN
Study. Cardiorenal Med 2011;1:53-66.
Whaley-Connell A, Shlipak M, Stevens, LA, Saab G, Szpunar SM,
Bomback AS, Tamura MK, McFarlane SI, Li S, Chen SC, Collins AJ,
Norris K, Bakris GL, McCullough PA. Awareness of Kidney Disease
and Relationship to End-Stage Renal Disease and Mortality. Am
J Med 2012;125:661-669. a)Editorial – Lien YHH. Mystery of
Chronic Kidney Disease Awareness. Am J Med. 2012:125(7):625627.
Whaley-Connell A, Sowers JR. Aldosterone and Risk for Insulin
Resistance. Hypertension. 2011;58:998-1000.
Whaley-Connell A, Sowers JR. Does initial choice of antihypertensive matter for cardiovascular outcomes in kidney
disease. Clin J Am Soc Nephrol. 2012;7(6):884-6.
Whaley-Connell A, Sowers JR. Indices of Obesity and
Cardiometabolic Risk. Hypertension. 2011;58:991-993.
Whaley-Connell A, Sowers JR. Oxidant Stress in the CardioRenal
Metabolic Syndrome. Curr Hypert Reports. 2012: 14(4):360-5.
Whaley-Connell A, Sowers JR. The Kaliuretic Impact of
Cicletanine Compared to Hydrochlorothiazide. J Hypertens
2012;30(4):691-2. PMID: 22418907.
Whaley-Connell A, Tamura MK, McCullough PA. A Decade
After the KDOQI CKD Guidelines – Impact on NKF-Kidney Early
Evaluation Program (KEEPTM). Am J Kid Dis. 2012, Nov:60(5):6923. Doi: 10.1053/j.ajkd.2012.08.008.
Whaley-Connell A, Vassalotti JA, Collins AJ, Chen SC, McCullough
PA. The National Kidney Foundation’s Kidney Early Evaluation
Program (KEEPTM) Annual Data Report 2011: Executive Summary.
Am J Kid Dis 2012;59(3)(suppl 2):S1-S4.
Whaley-Connell A. Perspectives in Diabetes Management for
Patients with Renal Impairment. American Health and Drug
Benefits. 2011.
Whaley-Connell A. The importance of proteinuria. International
Circulation. Published in print (2011 Japan) and on-line www.
ici